Avatar for HepaTx

Revolutionary stem cell-based therapies for liver disease

Revolutionary stem cell-based therapies for liver disease

Hepatx is developing cellular therapies to address the need for treatments for patients with life-threatening liver disease. Hepatx uses proprietary technology from Stanford University to manufacture induced hepatocytes (liver cells) to replace those lost to disease through a simple infusion.

HepaTx hasn't added any jobs yet

Get notified when HepaTx posts new jobs.

See similar jobs

Mark Chao

Avatar for Mark Chao
Early employee @Calydon, founder @GeneSource, Inc., Dir. ClinicalScientific Affairs @Asthmatx, Genomic Health, Inc., founder @VMWA LLC, founder @HepaTx
Total raised

$2.1M

Funded over

1 round

Latest round

Seed (Jul 2018)